Honokiol, a multifunctional tumor cell death inducer

Pharmazie

Volumn 67, Issue 10, 2012, Pages 811-816

  Tian, Wei ^a,b   Xu, Dong ^a,b   Deng, Yong Chuan ^b  

^a China National Ministry of Education   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CASPASE 8; CYCLOSPORIN A; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; DEXVERAPAMIL; ENDONUCLEASE G; FLICE INHIBITORY PROTEIN; HONOKIOL; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TAMOXIFEN; TARIQUIDAR; TRASTUZUMAB; VALSPODAR;

APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER THERAPY; CELL DEATH; CELL SURFACE; CHINESE MEDICINE; CHROMATIN; DNA FRAGMENTATION; DNA REPAIR; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; HEPATOMA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; MELANOMA CELL; MEMBRANE RUPTURE; MULTIDRUG RESISTANCE; NECROPTOSIS; PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIPHENYL COMPOUNDS; CELL DEATH; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; HUMANS; LIGNANS;

EID: 84868273888     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1854     Document Type: Review

References (47)

1. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB (2006) Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4: 621-633. (Pubitemid 44497215)
2. Battle TE, Arbiser J, Frank DA(2005) The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (BCLL) cells. Blood 106: 690-697. (Pubitemid 40981267)
3. Beguleya BC (2010) Multiple drug resistance mechanisms in cancer. Mol Biotechnol 46: 308-316.
4. Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237. (Pubitemid 40314954)
5. Chen XR, Lu R, Dan HX, Liao G, Zhou M, Li XY, Ji N (2011) Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci 3: 34-42.
6. Chen YJ, Wu CL, Liu JF, Fong YC, Hsu SF, Li TM, Su YC, Liu SH, Tang CH (2010) Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Lett 291: 20-30.
7. Danial NN, Korsmeyr SJ (2004) Cell death: critical control points. Cell 116: 205-219. (Pubitemid 38167313)
8. Deng J, Qian Y, Geng L, Chen J, Wang X, Xie H, Yan S, Jiang G, Zhou L, Zheng S (2008) Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28: 1458-1464.
9. Festjens N, Vanden Berghe T, Vandenabeele P (2006) Necrosis, a wellorchestrated form of cell demise:signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 1757: 1371-1387. (Pubitemid 44472550)
10. Forte M, Bernardi P (2006) The permeability transition and BCL-2 family proteins in apoptosis: co-conspirators or independent agents? Cell Death Differ 13: 1287-1290. (Pubitemid 44057461)
11. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
12. Gandhi L, Harding MW, Neubauer M, Langer CJ, Moore M, Ross HJ, Johnson BE, Lynch TJ (2007) A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer. Cancer 109: 924-932. (Pubitemid 46333534)
13. Golstein P, Kroemer G (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 32: 37-43. (Pubitemid 46043552)
14. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58. (Pubitemid 37328807)
15. Hersey P, Zhuang L, Zhang XD (2006) Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. Int Rev Cytol 251: 131-158. (Pubitemid 44291415)
16. Hibasami H, Achiwa Y, Katsuzaki H, Imai K, Yoshioka K, Nakanishi K, Ishii Y, Hasegawa M, Komiya T (1998) Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2: 671-673.
17. Hirano T, Gotho M, Oka K (1994) Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 55: 1061-1069.
18. Hu X, Han W, Li L (2007) Targeting the weak point of cancer by induction of necroptosis. Autophagy 3: 490-492. (Pubitemid 47293736)
19. Hu X, Xuan Y (2008) Bypassing cancer drug resistance by activating multiple death pathways-a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.Cancer Cancer Lett 259: 127-137. (Pubitemid 50015326)
20. Iannolo G, Conticello C, Memeo L, De Maria R (2008) Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66: 42-51. (Pubitemid 351330196)
21. Igney FH, Krammer PH (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288. (Pubitemid 37328781)
22. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC (2005) Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106: 1794-1800. (Pubitemid 41208596)
23. Li L, Han W, Gu Y, Qiu S, Lu Q, Jin J, Luo J, Hu X (2007) Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67: 4894-4903. (Pubitemid 46910198)
24. Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y (2008) Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 140: 95-102.
25. Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kuhnl A, Schulz CO, Elstner E, Possinger K, Eucker J (2008) Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591 (1-3): 43-51.
26. Mannal PW, Schneider J, Tangada A, McDonald D, McFadden DW (2011) Honokiol produces anti-neoplastic effects on melanoma cells in vitro. J Surg Oncol 104: 260-264.
27. Melino G (2001) The Sirens' song. Nature 412: 23.
28. Danial NN (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13: 7254-7263.
29. Olson JM, Hallahan AR (2004) p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med 10: 125-129. (Pubitemid 38293348)
30. Osford SM, Dallman CL, Johnson PW, Ganesan A, Packham G (2004) Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr Med Chem 11: 1031-1039.
31. Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK (2009) Down-regulation of c-Src/EGFRmediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 277: 133-140.
32. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G (2007) Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27: 3920-3935. (Pubitemid 47010991)
33. Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser JL, Khuri FR, Sun SY (2008) The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Mol Cancer Ther 7: 2212-2223.
34. Ruff P, Vorobioff D, Jordaan JP, Demetriou GS, Moodley SD, Nosworthy AL, Werner ID, Raats J, Burgess LJ (2009) A randomized, placebocontrolled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen. Cancer Chemother Pharmacol 64: 763-768.
35. Sharma SV, Gajowniczek P, Way IP, Lee DY, Jiang J, Yuza Y, Classon M, Haber DA, Settleman J. (2006) A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10: 425-435.
36. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW (2007) Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109: 1279-1289. (Pubitemid 46466554)
37. Singh T, Katiyar SK (2011) Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2. Int J Oncol 38: 769-776.
38. Sperandio S, de Belle J, Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97: 14376-14381. (Pubitemid 32016583)
39. Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE (2004) Paraptosis: mediation by MAP kinases and inhibition by AIP- 1/Alix. Cell Death Differ 11: 1066-1075. (Pubitemid 39341632)
40. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219-234. (Pubitemid 43336035)
41. Twiddy D, Brown DG, Adrain C, Jukes R, Martin SJ, Cohen GM, Mac- Farlane M, Cain K (2004) Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 279: 19665-19682. (Pubitemid 38623404)
42. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ,Vandenabeele P (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9:1031-1042.
43. Vandenabeele P, Galluzzi L,Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714.
44. Wang Y, Yang Z, Zhao X (2010) Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells. Toxicol Mech Methods 20: 234-241.
45. Wolf I, O'Kelly J,Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP (2007) Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 30: 1529-1537.
46. Xu D. Lu Q, Hu X (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280. (Pubitemid 44485849)
47. Yang SE, Hsieh MT, Tsai TH, Hsu SL (2002) Down-modulation of Bcl- XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63: 1641-1651.